{"entity":{"type":"insider","cik":"0001320982","url":"/insider/0001320982","json_url":"/insider/0001320982.json","name":"Konidaris Tasos","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2025-03-07","last":"2025-08-15","span_basis":"filed_date"},"name_variants":[{"name":"Konidaris Tasos","source":"filing","n_filings":2,"first_seen":"2025-03-07","last_seen":"2025-08-15"}],"transactions":[{"id":4389577,"accession":"0001723128-25-000051","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001723128-25-000051","line_url":"/filing/0001723128-25-000051#line-3","is_derivative":false,"issuer_cik":"0001320982","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001320982","owner_cik":"0001320982","owner_name":"Konidaris Tasos","owner_display_name":"Konidaris Tasos","owner_url":"/insider/0001320982","role":"Officer (Executive Vice President & CFO)","role_mark":"O","role_mark_label":"Officer (Executive Vice President & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President & CFO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":219159.0,"shares_display":"219,159","price_per_share":9.43,"price_display":"9.43","price_state":"stated","total_value":2066669.37,"total_display":"2,066,669.37","total_whole":"2,066,669","shares_owned_after":122152.0,"shares_owned_after_display":"122,152","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-15","scope":"insider"},{"id":4389573,"accession":"0001723128-25-000051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001723128-25-000051","line_url":"/filing/0001723128-25-000051#line-2","is_derivative":false,"issuer_cik":"0001320982","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001320982","owner_cik":"0001320982","owner_name":"Konidaris Tasos","owner_display_name":"Konidaris Tasos","owner_url":"/insider/0001320982","role":"Officer (Executive Vice President & CFO)","role_mark":"O","role_mark_label":"Officer (Executive Vice President & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President & CFO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":119206.0,"shares_display":"119,206","price_per_share":9.3,"price_display":"9.30","price_state":"stated","total_value":1108615.8,"total_display":"1,108,615.80","total_whole":"1,108,616","shares_owned_after":341311.0,"shares_owned_after_display":"341,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-14","filed_date":"2025-08-15","scope":"insider"},{"id":4389567,"accession":"0001723128-25-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001723128-25-000051","line_url":"/filing/0001723128-25-000051#line-1","is_derivative":false,"issuer_cik":"0001320982","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001320982","owner_cik":"0001320982","owner_name":"Konidaris Tasos","owner_display_name":"Konidaris Tasos","owner_url":"/insider/0001320982","role":"Officer (Executive Vice President & CFO)","role_mark":"O","role_mark_label":"Officer (Executive Vice President & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President & CFO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":161365.0,"shares_display":"161,365","price_per_share":9.22,"price_display":"9.22","price_state":"stated","total_value":1487785.3,"total_display":"1,487,785.30","total_whole":"1,487,785","shares_owned_after":460517.0,"shares_owned_after_display":"460,517","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-15","scope":"insider"},{"id":4633672,"accession":"0001628280-25-011303","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-011303","line_url":"/filing/0001628280-25-011303#line-1","is_derivative":false,"issuer_cik":"0001320982","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001320982","owner_cik":"0001320982","owner_name":"Konidaris Tasos","owner_display_name":"Konidaris Tasos","owner_url":"/insider/0001320982","role":"Officer (Executive Vice President & CFO)","role_mark":"O","role_mark_label":"Officer (Executive Vice President & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President & CFO","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":8.91,"price_display":"8.91","price_state":"stated","total_value":891000.0,"total_display":"891,000.00","total_whole":"891,000","shares_owned_after":621882.0,"shares_owned_after_display":"621,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001723128","name":"Amneal Pharmaceuticals, Inc.","url":"/issuer/0001723128","role":"Officer (Executive Vice President & CFO)","n_filings":2,"first_seen":"2025-03-07","last_seen":"2025-08-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001320982","retrieved_at":"2026-08-22T09:04:00+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}